GlassScriptPhysician profile
Philip A Philips
NPI 1346221686
$14,293.78
in general payments reported to CMS, 2019-2025
53 companies · $2,167 in 2025
The $2,167 reported for 2025 was more than what 83% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,321 · 2020: $257 · 2021: $3,505 · 2022: $1,134 · 2023: $2,709 · 2024: $2,201 · 2025: $2,167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,077.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,076.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $2,153.29 | 2021-2024 | Arista Ah Flexitip |
| Astrazeneca Pharmaceuticals LP | $1,405.71 | 2019-2025 | Calquence, Tagrisso, Lynparza |
| Glaxosmithkline, LLC. | $842.32 | 2021-2025 | Jemperli, Zejula, Ojjaara |
| E.R. Squibb & Sons, L.L.C. | $829.03 | 2019-2025 | Reblozyl, Breyanzi, Opdivo |
| Janssen Biotech, INC. | $590.16 | 2021-2025 | Carvykti, Rybrevant, Erleada |
| Eisai INC. | $549.37 | 2019-2024 | |
| Tesaro, INC. | $473.14 | 2019 | |
| Daiichi Sankyo INC. | $449.15 | 2023-2025 | Enhertu |
| Incyte Corporation | $446.38 | 2022-2025 | Jakafi, Monjuvi, Jakafi |
| Celgene Corporation | $345.79 | 2021 | |
| Jazz Pharmaceuticals INC. | $322.92 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $322.09 | 2024-2025 | |
| Exelixis INC. | $308.38 | 2023-2025 | Cabometyx |
| Kci USA, INC. | $300.11 | 2019 | |
| Myriad Genetic Laboratories, INC. | $259.33 | 2023 | Myrisk |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Philips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.